CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Rowinsky, MD
Chief Medical Officer Mitrabiotech
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- University of Colorado School of Medicine-Denver
Aurora, Colorado, United States
- Eastern Ct Hematology and Oncology Associates
Norwich, Connecticut, United States
- Lynn Cancer Institute
Boca Raton, Florida, United States
- Broward Oncology Associates
Fort Lauderdale, Florida, United States
- Holy Cross Hospital
Fort Lauderdale, Florida, United States
- University of Miami-Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- the Center for Gyencologic Oncology
Miramar, Florida, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Tallahassee Memorial Cancer Center
Tallahassee, Florida, United States
- Memorial Health University Medical Center- Savannah Health Services
Savannah, Georgia, United States
- Joliet Oncology Associates
Joliet, Illinois, United States
- Edward Elmhurst Healthcare
Naperville, Illinois, United States
- Community Hospital
Munster, Indiana, United States
- Ochsner Health System
New Orleans, Louisiana, United States
- Southcoast Centers for Cancer Care
Fairhaven, Massachusetts, United States
- Michigan Center of Medical Research -Mhp
Farmington Hills, Michigan, United States
- St John Hospital and Medical Center (great Lakes Cancer Managment Specialists)
Grosse Pointe Woods, Michigan, United States
- War Memorial Hematology/oncology
Sault Ste. Marie, Michigan, United States
- Mercy Hospital
St Louis, Missouri, United States
- University of Rochester/wilmot Cancer Institute
Rochester, New York, United States
- Saint Thomas Health
Nashville, Tennessee, United States
- Austin Cancer Centers
Austin, Texas, United States
- Doctors Hospital at Renaissance-Dhr Health
Edinburg, Texas, United States
- University of Texas Medical Branch at Galveston(utmb)
Galveston, Texas, United States
- Baylor College of Medicine Hemtology/oncology
Houston, Texas, United States
- Houston Methodist Medical Center
Houston, Texas, United States
- Oncology Consultants
Houston, Texas, United States
- the University of Texas Health Science Center at Houston- Hermann
Houston, Texas, United States
- Invesclinic Us Mcallen Oncology
McAllen, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jul 2017
- Primary completion
- 31 Jul 2019
- Completion
- 15 Dec 2019
- Last update posted
- 8 Apr 2019
- Registered enrollment
- 800
- Registry id
- NCT03253575
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.